Showing results (41-50 of 91) with videos related to
Sort By:
Pageof 10
BMC Cancer|May 18, 2021
FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancerAntoine Adenis, Thibault Mazard, Julien Fraisse, et al.Journal for Immunotherapy of Cancer|November 21, 2018
RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancerFanny Ledys, Quentin Klopfenstein, Caroline Truntzer, et al.Journal for Immunotherapy of Cancer|March 12, 2022
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancerJulie Lecuelle, Laure Favier, Cléa Fraisse, et al.Anticancer Research|May 29, 2017
Antibiotic Use Does Not Appear to Influence Response to NivolumabCoureche Kaderbhai, Corentin Richard, Jean David Fumet, et al.JTO Clinical and Research Reports|December 24, 2024
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLCChristian Rolfo, Laurent Greillier, Remi Veillon, et al.Cancer Research|November 6, 2025
Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T Cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite Stable Colorectal CancerJean-David Fumet, Charlène Latour, Lisa Nuttin, et al.Cell Reports|February 16, 2017
Neuropilin-1 Is Expressed on Lymphoid Tissue Residing LTi-like Group 3 Innate Lymphoid Cells and Associated with Ectopic Lymphoid AggregatesMedya Mara Shikhagaie, Åsa K Björklund, Jenny Mjösberg, et al.Cancer Immunology, Immunotherapy : CII|August 21, 2022
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinomaCaroline Laheurte, Evan Seffar, Eléonore Gravelin, et al.Oncotarget|August 4, 2016
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastomaAurélie Bertaut, Caroline Truntzer, Rachid Madkouri, et al.Frontiers in Oncology|August 8, 2024
Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancerGeorge Alzeeb, Corinne Tortorelli, Jaqueline Taleb, et al.Pageof 10